HCV/HBV coinfection: The dark side of DAAs treatment?
Liver Int
.
2017 Jul;37(7):1086-1087.
doi: 10.1111/liv.13342.
Epub 2016 Dec 28.
Authors
Salvatore Madonia
1
,
Emanuele Orlando
2
,
Giorgio Madonia
2
,
Marco Cannizzaro
2
Affiliations
1
Department of Medicine, V. Cervello Hospital, Palermo, Italy.
2
Department of Medicine, V. Cervello Hospital, University of Palermo, Palermo, Italy.
PMID:
27966812
DOI:
10.1111/liv.13342
No abstract available
Publication types
Letter
Comment
MeSH terms
Antiviral Agents
Coinfection*
HIV Infections
Hepatitis B
Hepatitis C*
Humans
Substances
Antiviral Agents